References
- Riddle O, Bates WR, Dykshorn WS. A new hormone of the anterior pituitary. Proc Soc Exp Biol Med 1932;29:1211–1212.
- Stricker P, Gruter F. Action du lobe anterieur de l'hypophyse sur la montee laiteuse. Comput Soc Biol 1928;99;1978–1980.
- Prabhakar VK, Davis JR. Hyperprolactinaemia. Best Pract Res Clin Obstet Gynaecol 2008;22:341–353.
- Speroff L, Glass R, Kase GN. The breast. Clinical and gynecological endocrinology and infertility, Philadelphia, USA: Lippincott, Williams & Wilkins; 1999.595–641.
- Sinkunas K, Rastenyte D, Deltuva VP, Knispelis R, Tamasauskas A. Transsphenoidal surgery for prolactinomas: results and prognosis. Medicina (Kanas) 2007;43:691–697.
- Berinder K, Stackenas I, Akre O, Hirschberg AL, Hulting AL. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clin Endocrinol (Oxf) 2005;63:450–455.
- Beshay VE, Beshay JE. Pituitary tumors: diagnosis, management, and implications for reproduction. Semin Reprod Med 2007;25:388–401.
- Zosmer A. Polycystic ovary syndrome. N Engl J Med 1996;334:668.
- Fahie-Wilson . The macroprolactinemia problem and its solution. South Med J 2006;99:1206.
- Hattori N, Nakayama Y, Kitagawa K, Ishihara T, Saiki Y, Inagaki C. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia. Clin Endocrinol (Oxf) 2008;68:72–76.
- Kavanagh-Wright L, Smith TP, Gibney J, McKenna TJ. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients, Clin Endocrinol (Oxf); 2009.70: 599–605.
- Leslie H, Courtney CH, Bell PM, Hadden DR, Macance DR, Eblis PK, Sheridan B, Atkinson AB. Laboratory and clinical experience in 55 patients with macroprolactinemia identifed by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 2001;86:2743–2746.
- The Practise Commitee of American Society for Reproductive Medicine. Current evaluation of amenorrhoea. Fertil Steril 2008;90(Suppl) S219–25.
- Rotterdam ESHRE/ASRM-Sponsored Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
- Mounier C, Trouillas J, Claustrat B, Duthel R, Estor B. Macroprolactinaemia associated with prolactin adenoma. Hum Reprod 2003;18:853–857.
- Moran C, Fonseca ME, Ochoa R, Mason M, Gama R, Zarate A. Molecular heterogeneity of prolactin and gonadotropins in some forms of sterility. Ginecol Obstet Mex 1990;58(Suppl 1): 9–13.
- Jackson RD, Wortsman J, Malarkey WB. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab 1985;61:258–264.
- Fideleff HL, Rubal G, Boquete H, Pujol A, Sequera A, Obrado P. Macroprolactinemia in childhood and adolescence: a cause of asymptomatic hyperprolactinemia. Horm Res 2000;53:16–19.
- Vilar L, Moura E, Canadas V, Gusmao A, Campos R, Leal E, Teixeira L, Santos V, Gomes B, Lima M, Paiża R, Alburqueque JL, Egito CS, Botelho CA, Azevedo M, Casulari LA, Naves LA. Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia. Arq Bras Endocrinol Metab 2007;51:86–91.